Indo Us Bio-Tech Balance Sheet Health
Financial Health criteria checks 5/6
Indo Us Bio-Tech has a total shareholder equity of ₹627.5M and total debt of ₹143.2M, which brings its debt-to-equity ratio to 22.8%. Its total assets and total liabilities are ₹844.6M and ₹217.1M respectively. Indo Us Bio-Tech's EBIT is ₹109.7M making its interest coverage ratio 8.1. It has cash and short-term investments of ₹11.0M.
Key information
22.8%
Debt to equity ratio
₹143.24m
Debt
| Interest coverage ratio | 8.1x |
| Cash | ₹10.98m |
| Equity | ₹627.47m |
| Total liabilities | ₹217.09m |
| Total assets | ₹844.56m |
Recent financial health updates
No updates
Recent updates
No updates
Financial Position Analysis
Short Term Liabilities: INDOUS's short term assets (₹730.9M) exceed its short term liabilities (₹174.6M).
Long Term Liabilities: INDOUS's short term assets (₹730.9M) exceed its long term liabilities (₹42.5M).
Debt to Equity History and Analysis
Debt Level: INDOUS's net debt to equity ratio (21.1%) is considered satisfactory.
Reducing Debt: INDOUS's debt to equity ratio has reduced from 36.4% to 22.8% over the past 5 years.
Debt Coverage: INDOUS's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: INDOUS's interest payments on its debt are well covered by EBIT (8.1x coverage).